Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2021

Jan 5, 2021

32641_dirs_2021-01-05_1ac428f0-3fdb-4f02-9e8b-cd4cc9fe4e24.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2020-11-07

Reporting Person: BURNETT JOSEPH MICHAEL (Director, CEO and President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-07 Common Stock F 5765 $6.65 Disposed 262366 Direct

Footnotes

F1: This amendment on Form 4/A to the original Form 4 filed on November 7, 2020 is made solely to correct the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted